Clin2
NCT07375862Possibly a fitNot yet recruiting

Danhong injection for heart problems caused by sepsis

Sepsis-Induced Myocardial Dysfunction

Part of Heart & circulation, Infections clinical trials.

This trial tests whether a traditional Chinese medicine called Danhong injection can help protect the heart when sepsis (a severe infection) causes heart damage. It aims to see if it improves heart function and recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have sepsis, a severe infection that affects your whole body.
  • Your heart has been weakened because of the sepsis (a condition called sepsis-related heart injury).
  • You do not have severe heart disease before the sepsis, such as unstable chest pain or severe heart failure.
  • You have not been using Danhong injection or other heart-affecting medications long-term recently.
  • Your liver and kidneys are working well enough (no severe liver failure or severe kidney disease).
  • You are not pregnant or breastfeeding, and you have no serious mental illness that would prevent cooperation.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686355Recruiting· Phase 2
Yiqilishui formula for sepsis-related heart problems

This trial tests a Chinese herbal formula called Yiqilishui in people with sepsis who have developed heart muscle weakness. It aims to see if the formula can help improve heart function.

Beijing
NCT06898723Recruiting· Phase 4
Shenfu injection to prevent heart problems in sepsis

This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.

Wuhu, Anhui
NCT06920420Not yet recruiting
Xuebijing injection for improving sepsis outcomes

This trial tests whether a herbal injection called Xuebijing, plus standard care, can improve recovery from sepsis. It aims to find new markers in the blood that may help predict how well the treatment works.

NCT06514339Recruiting· Early Phase 1
Shenhuang granules for sepsis treatment

This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.

Hangzhou, Zhejiang
NCT06915506Not yet recruiting· Phase 4
Shenfu injection for blood vessel health in sepsis

This study tests whether a traditional Chinese medicine called Shenfu injection can improve the flexibility of the carotid artery in people with sepsis or septic shock. It may help doctors understand if this treatment can reduce complications from severe infections.

Wuhu, Anhui
NCT07069894Not yet recruiting
Herbal injection for sepsis patients in the hospital

This trial tests a Chinese herbal medicine called Xuebijing, given as an injection, to see if it helps people with sepsis recover better. It is being studied in real-world hospital settings to understand how well it works outside of strict research conditions.

Nanjing, Jiangsu

Hear when a new Sepsis Induced Myocardial Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.